Caixia Gao
高彩霞
Caixia Gao is a researcher at the Chinese Academy of Sciences and a leading figure in China's agricultural gene-editing field, credited with creating the world's first CRISPR-Cas9 plant in 2013 . In 2021, she co-founded Qiheshengke Biotechnology with Kevin Zhao, a Harvard-trained scientist who studied under gene-editing pioneer David Liu . She serves as the company's co-founder and chief scientist . Her team's recent work includes developing PCE, a programmable chromosome engineering technology for large-fragment DNA manipulation published in *Cell* in 2024, building on their earlier PrimeRoot platform . Qiheshengke has advanced multiple gene-edited crops toward commercialization, including high-oleic soybeans and powdery-mildew-resistant wheat, and raised over 100 million RMB in a Pre-A round in 2023 with participation from Gaorong Ventures and Source Code Capital .
AI-generated — may contain errors, please verify.
Coverage
When a "Top-Tier" Gene-Editing Scientist Team Starts Caring About Seeds, Grains, and Vegetables | Gaorong Ventures
Let harvests be not only nature's gift, but also the fruit of technology.
Qihe Biotech Closes Over 100 Million Yuan Pre-A Round to Accelerate Development and Application of Novel Gene-Editing Technologies
Accelerate the commercialization of gene-edited breeding.
Qiheshengke Biotechnology Raises Over 100 Million RMB in Pre-A Round with Source Code Capital Participation
This round of funding will help Qiheshengke Biotechnology accelerate the commercialization of gene-edited bio-breeding.
